Immunoblotting results presented in Fig. 5G indicated that the KDM6 inhibitor GSK-J4 suppressed the expression of IGF1 and ELN in AOM/DSS-induced colon cancer but had minimal effect on KDM6A protein levels. This evidence concerns the gene ELN and malignant colon neoplasm.